ArticleFrontiers in immunology2026
Preclinical study on an adsorbed acellular diphtheria- tetanus-pertussis (reduced-dose) combined vaccine: evaluation of reproductive safety and immunogenicity.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The diphtheria, tetanus, and acellular pertussis combined vaccine (DTaP) is a trivalent formulation containing acellular pertussis antigens, diphtheria toxoid, and tetanus toxoid, and provides simultaneous protection against pertussis, diphtheria, and tetanus. This study aimed to systematically evaluate the effects of repeated intramuscular administration of an adsorbed acellular diphtheria-tetanus-pertussis (reduced-dose) combined vaccine (Tdacp) on gamete maturation, mating performance, fertility, and embryo-fetal development in Sprague-Dawley (SD) rats, thereby providing experimental evidence for its reproductive safety. Methods: Sexually mature SD rats were randomly assigned, stratified by sex and body weight into four groups: negative control, adjuvant control, low-dose, and high-dose, with 40 rats per group (20 males and 20 females). Male and female rats were paired for mating according to group assignment and identification number. Animals received two intramuscular injections; the low-dose group received 0.25 mL/rat, whereas all other groups received 0.5 mL/rat. Evaluated parameters included clinical signs, food consumption, body weight, reproductive organ coefficients, estrous cycle characteristics in females, sperm parameters in males, embryo-fetal growth and development, and vaccine-induced antibody responses. Results: Repeated intramuscular administration of Tdacp did not result in significant adverse effects on food consumption, body weight, or reproductive function in either the low-dose or high-dose group compared with the negative control group. Likewise, no treatment-related embryo-fetal developmental toxicity or teratogenic effects were observed. Although several embryo-fetal developmental parameters in the adjuvant control group, including implantation loss, fetal viability, embryo/fetal resorption, and selected skeletal ossification findings, differed from those in the negative control group, similar findings were not observed in the vaccine-treated groups. Immunogenicity analysis demonstrated positive antibody responses against diphtheria, tetanus, and pertussis antigens in both vaccine groups following immunization. Discussion: These findings indicate that Tdacp has a favorable reproductive safety profile and good immunogenicity in SD rats. The results provide important nonclinical evidence to support its further clinical development. Manufactured using advanced chromatographic purification technology, this combined vaccine may contribute to the establishment and implementation of a life-course pertussis prevention and immunization strategy in China.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.